Radient Pharmaceuticals Corporation (RPC) (NYSE Amex: RPC) announced it is attending and presenting at the 46th Annual Meeting of the American Society of Clinical Oncology (ASCO) in Chicago June 4-8, 2010. ASCO is the world's leading professional organization representing physicians who care for people with cancer. With more than 27,000 oncology practitioners as members, ASCO is committed to improving cancer care through scientific meetings, educational programs and peer-reviewed journals...
More...
More...